価格表

在庫・価格 : 2024年06月12日 10時03分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Influenza A virus PB1 protein, Rabbit
データシート
GTX125923 GNTジーンテックス
GeneTex International Corporation
25 μl ¥24,000
(未発注)
追加

在庫・価格 : 2024年06月12日 10時03分 現在

Anti-Influenza A virus PB1 protein, Rabbit

  • 商品コード:GTX125923
  • メーカー:GNT
  • 包装:25μl
  • 価格: ¥24,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Hsu SF et al. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication. J. Virol. 2015 Apr;89(7):3671-82
Hsu SF et al
2015/01/01
Application: Western blot, Reactivity: Human PubMed
2 Su WC et al. A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription. J. Virol. 2015 Nov;89(22):11245-55
Su WC et al
2015/01/01
PubMed
3 Arai Y et al. Novel Polymerase Gene Mutations for Human Adaptation in Clinical Isolates of Avian H5N1 Influenza Viruses. PLoS Pathog. 2016 Apr;12(4):e1005583
Arai Y et al
2016/01/01
PubMed
4 Du Y et al. Annotating Protein Functional Residues by Coupling High-Throughput Fitness Profile and Homologous-Structure Analysis. MBio 2016 Nov;7(6)
Du Y et al
2016/01/01
PubMed
5 Kuo SM et al. Inhibition of Avian Influenza A Virus Replication in Human Cells by Host Restriction Factor TUFM Is Correlated with Autophagy. MBio 2017 06;8(3)
Kuo SM et al
2017/01/01
Application: Western blot PubMed
6 Watanabe K et al. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction. Sci Rep 2017 Aug;7(1):9500
Watanabe K et al
2017/01/01
Application: Western Blot (WB) PubMed
7 Oymans J et al. A Mechanism for Priming and Realignment during Influenza A Virus Replication. J. Virol. 2018 02;92(3)
Oymans J et al
2018/01/01
Application: Western Blot (WB) PubMed
8 Wang J et al. Host Long Noncoding RNA lncRNA-PAAN Regulates the Replication of Influenza A Virus. Viruses 2018 06;10(6)
Wang J et al
2018/01/01
Application: Western Blot (WB) PubMed
9 Lin HT et al. Grail attenuates influenza A virus infection and pathogenesis by inhibiting viral nucleoprotein. Sci Rep 2018 Nov;8(1):17242
Lin HT et al
2018/01/01
Application: Western Blot PubMed
10 Yang C et al. The nucleolar protein LYAR facilitates ribonucleoprotein assembly of influenza A virus. J. Virol. 2018 Sep;
Yang C et al
2018/01/01
Application: Western Blot,Immunocytochemistry/ Immunofluorescence PubMed
11 Zhang J et al. Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses. Eur J Pharm Sci 2019 May;133:86-94
Zhang J et al
2019/01/01
Application: Western Blot PubMed
12 Mohl G et al. Novel influenza inhibitors designed to target PB1 interactions with host importin RanBP5. Antiviral Res. 2019 Apr;164:81-90
Mohl G et al
2019/01/01
PubMed
13 Li J et al. MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 protein. Biochem. J. 2019 Feb;476(3):467-481
Li J et al
2019/01/01
Application: Western Blot PubMed
14 Walker AP et al. Mutation of an Influenza Virus Polymerase 3" RNA Promoter Binding Site Inhibits Transcription Elongation. J. Virol. 2020 Jun;94(13)
Walker AP et al
2020/01/01
PubMed
15 Zhang T et al. Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis. Cell 2020 Mar;180(6):1115-1129.e13
Zhang T et al
2020/01/01
PubMed
16 Hu A et al. Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase. Front Microbiol 2020;11:178
Hu A et al
2020/01/01
PubMed
17 Chao TL et al. Characterization of Influenza A Virus Infection in Mouse Pulmonary Stem/Progenitor Cells. Front Microbiol 2019;10:2942
Chao TL et al
2019/01/01
PubMed
18 Hao X et al. The PB2 and M genes are critical for the superiority of genotype S H9N2 virus to genotype H in optimizing viral fitness of H5Nx and H7N9 avian influenza viruses in mice. Transbound Emerg Dis 2020 Mar;67(2):758-768
Hao X et al
2020/01/01
PubMed
19 Choi JG et al. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition. Sci Rep 2019 08;9(1):12132
Choi JG et al
2019/01/01
PubMed
20 Hao X et al. The PB2 and M genes of genotype S H9N2 virus contribute to the enhanced fitness of H5Nx and H7N9 avian influenza viruses in chickens. Virology 2019 09;535:218-226
Hao X et al
2019/01/01
PubMed
21 Arai Y et al. PB2 mutations arising during H9N2 influenza evolution in the Middle East confer enhanced replication and growth in mammals. PLoS Pathog. 2019 07;15(7):e1007919
Arai Y et al
2019/01/01
PubMed
22 Russell AB et al. Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity. J. Virol. 2019 07;93(14)
Russell AB et al
2019/01/01
PubMed
23 Zheng W et al. Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export. Cell Rep 2019 05;27(6):1875-1885.e5
Zheng W et al
2019/01/01
PubMed
24 Wang R et al. Autophagy Promotes Replication of Influenza A Virus <i>In Vitro</i>. J. Virol. 2019 Feb;93(4)
Wang R et al
2019/01/01
PubMed
25 Nilsson-Payant BE et al. The Surface-Exposed PA<sup>51-72</sup>-Loop of the Influenza A Virus Polymerase Is Required for Viral Genome Replication. J. Virol. 2018 08;92(16)
Nilsson-Payant BE et al
2018/01/01
PubMed
26 Gong W et al. Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly. J Virol 2021 Mar;
Gong W et al
2021/01/01
PubMed
27 Sarto J.D. et al., Sarto J.D., bioRxiv, 2021

PubMed
28 Zhu Y et al. Human TRA2A determines influenza A virus host adaptation by regulating viral mRNA splicing. Sci Adv 2020 Jun;6(25):eaaz5764
Zhu Y et al
2020/01/01
PubMed
29 Sun N et al. Type-IInterferon-Inducible SERTAD3 Inhibits Influenza A Virus Replication by Blocking the Assembly of Viral RNA Polymerase Complex. Cell Rep 2020 11;33(5):108342
Sun N et al
2020/01/01
PubMed
30 Gao Q et al. Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus. J Virol 2020 12;95(2)
Gao Q et al
2020/01/01
PubMed
31 Carrique L et al. Host ANP32A mediates the assembly of the influenza virus replicase. Nature 2020 11;587(7835):638-643
Carrique L et al
2020/01/01
PubMed
32 Chida J et al. Prion protein signaling induces M2 macrophage polarization and protects from lethal influenza infection in mice. PLoS Pathog 2020 08;16(8):e1008823
Chida J et al
2020/01/01
PubMed
33 Zhang X et al. Avian Chaperonin Containing TCP1 Subunit 5 Supports Influenza A Virus Replication by Interacting With Viral Nucleoprotein, PB1, and PB2 Proteins. Front Microbiol 2020;11:538355
Zhang X et al
2020/01/01
PubMed
34 Chen SC et al. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs. J. Virol. 2017 10;91(20)
Chen SC et al
2017/01/01
PubMed
35 Oymans J et al., Oymans J, bioRxiv, 2017

PubMed
36 Liu X et al. MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes. Nat Commun 2021 07;12(1):4427
Liu X et al
2021/01/01
PubMed
37 Deinhardt-Emmer S et al. Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice. Biomolecules 2021 05;11(6)
Deinhardt-Emmer S et al
2021/01/01
PubMed
38 Froggatt HM et al. Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity. PLoS Pathog 2021 09;17(9):e1009951
Froggatt HM et al
2021/01/01
PubMed
39 Ma C et al. p21 restricts influenza A virus by perturbing the viral polymerase complex and upregulating type I interferon signaling. PLoS Pathog 2022 Feb;18(2):e1010295
Ma C et al
2022/01/01
PubMed
40 Gerlt V et al. Cellular Protein Phosphatase 2A Regulates Cell Survival Mechanisms in Influenza A Virus Infection. Int J Mol Sci 2021 Oct;22(20)
Gerlt V et al
2021/01/01
PubMed
41 Patil A et al. Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function. J Virol 2021 Feb;95(6)
Patil A et al
2021/01/01
PubMed
42 Li J et al. Viral RNA-binding ability conferred by SUMOylation at PB1 K612 of influenza A virus is essential for viral pathogenesis and transmission. PLoS Pathog 2021 Feb;17(2):e1009336
Li J et al
2021/01/01
PubMed
43 Fernbach S et al. Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense. Cell Rep 2022 Mar;38(12):110549
Fernbach S et al
2022/01/01
PubMed
44 Zhao J et al. An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA. Nat Commun 2022 Apr;13(1):2079
Zhao J et al
2022/01/01
PubMed
45 WK Cho et al., Hoveniae Semen Seu Fructus water extract inhibits influenza A virus infection, J Funct ?Foods., 2024., 112()., 105940

PubMed
46 Ma L et al. Mutual antagonism of mouse-adaptation mutations in HA and PA proteins on H9N2 virus replication. Virol Sin 2024 Feb;39(1):56-70
Ma L et al
2024/01/01
PubMed
47 Lamb C et al. Quantification of influenza virus mini viral RNA dynamics using Cas13. bioRxiv 2024 May;
Lamb C et al
2024/01/01
PubMed
48 Sheppard CM et al. An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization. Nat Commun 2023 Oct;14(1):6135
Sheppard CM et al
2023/01/01
PubMed
49 Rigby CV et al. Evolution of&#xA0;transient RNA structure-RNA polymerase interactions in&#xA0;respiratory RNA virus genomes. Virus Evol 2023;9(2):vead056
Rigby CV et al
2023/01/01
PubMed
50 Yang H et al. The synergistic effect of residues 32T and 550L in the PA protein of H5 subtype avian influenza virus contributes to viral pathogenicity in mice. PLoS Pathog 2023 Jul;19(7):e1011489
Yang H et al
2023/01/01
PubMed
51 Rigby C et al. Evolution of transient RNA structure-RNA polymerase interactions in respiratory RNA virus genomes. bioRxiv 2023 Aug;
Rigby C et al
2023/01/01
PubMed
52 Chen J et al. Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells. Virol Sin 2023 Feb;38(1):128-141
Chen J et al
2023/01/01
PubMed
53 Zheng H et al. G Protein Subunit &#x3B2;1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2. J Virol 2022 Jun;96(12):e0049422
Zheng H et al
2022/01/01
PubMed
54 G端nl F et al. The ubiquitination landscape of the influenza A virus polymerase. Nat Commun 2023 Feb;14(1):787
G端nl F et al
2023/01/01
PubMed
55 Li Q et al. SRSF5-Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host-Directed Target Against Influenza Virus. Adv Sci (Weinh) 2022 Dec;9(34):e2203088
Li Q et al
2022/01/01
PubMed
56 French H et al. Transient RNA structures cause aberrant influenza virus replication and innate immune activation. Sci Adv 2022 Sep;8(36):eabp8655
French H et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Hsu SF et al. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication. J. Virol. 2015 Apr;89(7):3671-82
    Hsu SF et al
    2015/01/01
  • 備考:
    Application: Western blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Su WC et al. A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription. J. Virol. 2015 Nov;89(22):11245-55
    Su WC et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Arai Y et al. Novel Polymerase Gene Mutations for Human Adaptation in Clinical Isolates of Avian H5N1 Influenza Viruses. PLoS Pathog. 2016 Apr;12(4):e1005583
    Arai Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Du Y et al. Annotating Protein Functional Residues by Coupling High-Throughput Fitness Profile and Homologous-Structure Analysis. MBio 2016 Nov;7(6)
    Du Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kuo SM et al. Inhibition of Avian Influenza A Virus Replication in Human Cells by Host Restriction Factor TUFM Is Correlated with Autophagy. MBio 2017 06;8(3)
    Kuo SM et al
    2017/01/01
  • 備考:
    Application: Western blot
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Watanabe K et al. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction. Sci Rep 2017 Aug;7(1):9500
    Watanabe K et al
    2017/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Oymans J et al. A Mechanism for Priming and Realignment during Influenza A Virus Replication. J. Virol. 2018 02;92(3)
    Oymans J et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Wang J et al. Host Long Noncoding RNA lncRNA-PAAN Regulates the Replication of Influenza A Virus. Viruses 2018 06;10(6)
    Wang J et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Lin HT et al. Grail attenuates influenza A virus infection and pathogenesis by inhibiting viral nucleoprotein. Sci Rep 2018 Nov;8(1):17242
    Lin HT et al
    2018/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Yang C et al. The nucleolar protein LYAR facilitates ribonucleoprotein assembly of influenza A virus. J. Virol. 2018 Sep;
    Yang C et al
    2018/01/01
  • 備考:
    Application: Western Blot,Immunocytochemistry/ Immunofluorescence
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Zhang J et al. Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses. Eur J Pharm Sci 2019 May;133:86-94
    Zhang J et al
    2019/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Mohl G et al. Novel influenza inhibitors designed to target PB1 interactions with host importin RanBP5. Antiviral Res. 2019 Apr;164:81-90
    Mohl G et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Li J et al. MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 protein. Biochem. J. 2019 Feb;476(3):467-481
    Li J et al
    2019/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Walker AP et al. Mutation of an Influenza Virus Polymerase 3&quot; RNA Promoter Binding Site Inhibits Transcription Elongation. J. Virol. 2020 Jun;94(13)
    Walker AP et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Zhang T et al. Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis. Cell 2020 Mar;180(6):1115-1129.e13
    Zhang T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Hu A et al. Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase. Front Microbiol 2020;11:178
    Hu A et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Chao TL et al. Characterization of Influenza A Virus Infection in Mouse Pulmonary Stem/Progenitor Cells. Front Microbiol 2019;10:2942
    Chao TL et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Hao X et al. The PB2 and M genes are critical for the superiority of genotype S H9N2 virus to genotype H in optimizing viral fitness of H5Nx and H7N9 avian influenza viruses in mice. Transbound Emerg Dis 2020 Mar;67(2):758-768
    Hao X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Choi JG et al. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition. Sci Rep 2019 08;9(1):12132
    Choi JG et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Hao X et al. The PB2 and M genes of genotype S H9N2 virus contribute to the enhanced fitness of H5Nx and H7N9 avian influenza viruses in chickens. Virology 2019 09;535:218-226
    Hao X et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Arai Y et al. PB2 mutations arising during H9N2 influenza evolution in the Middle East confer enhanced replication and growth in mammals. PLoS Pathog. 2019 07;15(7):e1007919
    Arai Y et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Russell AB et al. Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity. J. Virol. 2019 07;93(14)
    Russell AB et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Zheng W et al. Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export. Cell Rep 2019 05;27(6):1875-1885.e5
    Zheng W et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Wang R et al. Autophagy Promotes Replication of Influenza A Virus <i>In Vitro</i>. J. Virol. 2019 Feb;93(4)
    Wang R et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Nilsson-Payant BE et al. The Surface-Exposed PA<sup>51-72</sup>-Loop of the Influenza A Virus Polymerase Is Required for Viral Genome Replication. J. Virol. 2018 08;92(16)
    Nilsson-Payant BE et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Gong W et al. Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly. J Virol 2021 Mar;
    Gong W et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Sarto J.D. et al., Sarto J.D., bioRxiv, 2021

  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Zhu Y et al. Human TRA2A determines influenza A virus host adaptation by regulating viral mRNA splicing. Sci Adv 2020 Jun;6(25):eaaz5764
    Zhu Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Sun N et al. Type-IInterferon-Inducible SERTAD3 Inhibits Influenza A Virus Replication by Blocking the Assembly of Viral RNA Polymerase Complex. Cell Rep 2020 11;33(5):108342
    Sun N et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Gao Q et al. Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus. J Virol 2020 12;95(2)
    Gao Q et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Carrique L et al. Host ANP32A mediates the assembly of the influenza virus replicase. Nature 2020 11;587(7835):638-643
    Carrique L et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Chida J et al. Prion protein signaling induces M2 macrophage polarization and protects from lethal influenza infection in mice. PLoS Pathog 2020 08;16(8):e1008823
    Chida J et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Zhang X et al. Avian Chaperonin Containing TCP1 Subunit 5 Supports Influenza A Virus Replication by Interacting With Viral Nucleoprotein, PB1, and PB2 Proteins. Front Microbiol 2020;11:538355
    Zhang X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Chen SC et al. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs. J. Virol. 2017 10;91(20)
    Chen SC et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Oymans J et al., Oymans J, bioRxiv, 2017

  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Liu X et al. MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes. Nat Commun 2021 07;12(1):4427
    Liu X et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Deinhardt-Emmer S et al. Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice. Biomolecules 2021 05;11(6)
    Deinhardt-Emmer S et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Froggatt HM et al. Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity. PLoS Pathog 2021 09;17(9):e1009951
    Froggatt HM et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Ma C et al. p21 restricts influenza A virus by perturbing the viral polymerase complex and upregulating type I interferon signaling. PLoS Pathog 2022 Feb;18(2):e1010295
    Ma C et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Gerlt V et al. Cellular Protein Phosphatase 2A Regulates Cell Survival Mechanisms in Influenza A Virus Infection. Int J Mol Sci 2021 Oct;22(20)
    Gerlt V et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Patil A et al. Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function. J Virol 2021 Feb;95(6)
    Patil A et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Li J et al. Viral RNA-binding ability conferred by SUMOylation at PB1 K612 of influenza A virus is essential for viral pathogenesis and transmission. PLoS Pathog 2021 Feb;17(2):e1009336
    Li J et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Fernbach S et al. Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense. Cell Rep 2022 Mar;38(12):110549
    Fernbach S et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Zhao J et al. An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA. Nat Commun 2022 Apr;13(1):2079
    Zhao J et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    WK Cho et al., Hoveniae Semen Seu Fructus water extract inhibits influenza A virus infection, J Funct ?Foods., 2024., 112()., 105940

  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Ma L et al. Mutual antagonism of mouse-adaptation mutations in HA and PA proteins on H9N2 virus replication. Virol Sin 2024 Feb;39(1):56-70
    Ma L et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Lamb C et al. Quantification of influenza virus mini viral RNA dynamics using Cas13. bioRxiv 2024 May;
    Lamb C et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Sheppard CM et al. An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization. Nat Commun 2023 Oct;14(1):6135
    Sheppard CM et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Rigby CV et al. Evolution of&#xA0;transient RNA structure-RNA polymerase interactions in&#xA0;respiratory RNA virus genomes. Virus Evol 2023;9(2):vead056
    Rigby CV et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Yang H et al. The synergistic effect of residues 32T and 550L in the PA protein of H5 subtype avian influenza virus contributes to viral pathogenicity in mice. PLoS Pathog 2023 Jul;19(7):e1011489
    Yang H et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Rigby C et al. Evolution of transient RNA structure-RNA polymerase interactions in respiratory RNA virus genomes. bioRxiv 2023 Aug;
    Rigby C et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Chen J et al. Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells. Virol Sin 2023 Feb;38(1):128-141
    Chen J et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Zheng H et al. G Protein Subunit &#x3B2;1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2. J Virol 2022 Jun;96(12):e0049422
    Zheng H et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    G端nl F et al. The ubiquitination landscape of the influenza A virus polymerase. Nat Commun 2023 Feb;14(1):787
    G端nl F et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Li Q et al. SRSF5-Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host-Directed Target Against Influenza Virus. Adv Sci (Weinh) 2022 Dec;9(34):e2203088
    Li Q et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    French H et al. Transient RNA structures cause aberrant influenza virus replication and innate immune activation. Sci Adv 2022 Sep;8(36):eabp8655
    French H et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed